Irinotecan for the adjuvant treatment of colon cancer
Status Suspended
Decision Selected
Process TA
Referral date 01 June 2004
Topic area
  • Cancer
  • Digestive system

Provisional Schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: 01 January 2100
2nd appraisal committee meeting TBC

Project Team

Assessment Group / Evidence Review Group: TBC
Communications manager: Philip Ranson
Executive Lead: Peter Littlejohns
Project manager:

Cathryn Fuller

Technical Lead: Zoe Garrett


Key events during the development of the guidance:

Date Update
17 August 2004 Topic summary published.
28 October 2004 Provision schedule updated.
25 January 2005 Project manager updated.
27 May 2005 Provisional schedule updated.
13 September 2005 Technology appraisal manager updated.
20 October 2005 Appraisal title amended.
16 November 2005 Letter to consultees and commentators regarding suspension of the appraisal added.
18 November 2005 Appraisal status changed. Appraisal suspended.
25 August 2006 This topic was transferred to the Single technology appraisal (STA) process as part of the Institute's 12th wave work programme.

For further information on our processes and methods, please see our CHTE processes and methods manual